Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Peritoneal mesothelioma.

Hesdorffer ME, Chabot J, DeRosa C, Taub R.

Curr Treat Options Oncol. 2008 Jun;9(2-3):180-90. doi: 10.1007/s11864-008-0072-2. Epub 2008 Oct 8. Review.

PMID:
18841478
2.

Peritoneal mesothelioma.

Taub RN, Keohan ML, Chabot JC, Fountain KS, Plitsas M.

Curr Treat Options Oncol. 2000 Oct;1(4):303-12. Review.

PMID:
12057156
3.

Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for malignant peritoneal mesothelioma: mitomycin versus cisplatin.

Blackham AU, Shen P, Stewart JH, Russell GB, Levine EA.

Ann Surg Oncol. 2010 Oct;17(10):2720-7. doi: 10.1245/s10434-010-1080-6. Epub 2010 Apr 27. Erratum in: Ann Surg Oncol. 2011 Dec;18 Suppl 3:S325-6.

PMID:
20422458
4.

Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for the treatment of malignant peritoneal mesothelioma.

Hesdorffer ME, Chabot JA, Keohan ML, Fountain K, Talbot S, Gabay M, Valentin C, Lee SM, Taub RN.

Am J Clin Oncol. 2008 Feb;31(1):49-54. doi: 10.1097/COC.0b013e3180684181.

PMID:
18376228
5.

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma.

Tan GH, Cheung M, Chanyaputhipong J, Soo KC, Teo MC.

Ann Acad Med Singapore. 2013 Jun;42(6):291-6.

6.

Diagnosis and treatment of peritoneal mesothelioma: The Washington Cancer Institute experience.

Sugarbaker PH, Acherman YI, Gonzalez-Moreno S, Ortega-Perez G, Stuart OA, Marchettini P, Yoo D.

Semin Oncol. 2002 Feb;29(1):51-61.

PMID:
11836669
7.

Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).

Baratti D, Kusamura S, Cabras AD, Dileo P, Laterza B, Deraco M.

Ann Surg Oncol. 2009 Feb;16(2):463-72. doi: 10.1245/s10434-008-0219-1. Epub 2008 Dec 12.

PMID:
19082859
8.

Patterns of failure following surgical resection for malignant pleural mesothelioma.

Jänne PA, Baldini EH.

Thorac Surg Clin. 2004 Nov;14(4):567-73. Review.

PMID:
15559064
9.

Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma.

de Bree E, van Ruth S, Baas P, Rutgers EJ, van Zandwijk N, Witkamp AJ, Zoetmulder FA.

Chest. 2002 Feb;121(2):480-7.

PMID:
11834661
11.

Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study.

Brigand C, Monneuse O, Mohamed F, Sayag-Beaujard AC, Isaac S, Gilly FN, Glehen O.

Ann Surg Oncol. 2006 Mar;13(3):405-12. Epub 2006 Jan 30.

PMID:
16485159
12.

Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.

Sugarbaker DJ, Gill RR, Yeap BY, Wolf AS, DaSilva MC, Baldini EH, Bueno R, Richards WG.

J Thorac Cardiovasc Surg. 2013 Apr;145(4):955-63. doi: 10.1016/j.jtcvs.2012.12.037. Epub 2013 Feb 21.

13.

Malignant pleural mesothelioma.

Chen SE, Pace MB.

Am J Health Syst Pharm. 2012 Mar 1;69(5):377-85. doi: 10.2146/ajhp110281. Review.

PMID:
22345416
14.

['Malignant peritoneal mesothelioma': a condition difficult to diagnose].

van der Valk FM, van Leeuwen J.

Ned Tijdschr Geneeskd. 2012;156(15):A4269. Dutch.

PMID:
22495008
15.

Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).

Baratti D, Kusamura S, Nonaka D, Oliva GD, Laterza B, Deraco M.

Ann Surg Oncol. 2007 Oct;14(10):2790-7. Epub 2007 Jul 28.

PMID:
17661150
16.

Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.

Deraco M, Nonaka D, Baratti D, Casali P, Rosai J, Younan R, Salvatore A, Cabras Ad AD, Kusamura S.

Ann Surg Oncol. 2006 Feb;13(2):229-37. Epub 2006 Jan 18.

PMID:
16444562
17.

Peritoneal mesothelioma.

Mohamed F, Sugarbaker PH.

Curr Treat Options Oncol. 2002 Oct;3(5):375-86. Review.

PMID:
12194803
18.

Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion.

Deraco M, Casali P, Inglese MG, Baratti D, Pennacchioli E, Bertulli R, Kusamura S.

J Surg Oncol. 2003 Jul;83(3):147-53.

PMID:
12827682
19.

[Malignant peritoneal mesothelioma. Our experienced with triple combined therapy: cytoreduction, intraperitoneal perioperative chemotherapy and hyperthermia].

Gómez Portilla A, Cendoya I, Muriel J, Olabarria I, Guede N, Moraza N, Fernández E, Martínez de Lecea C, Magrach L, Martín E, Romero E, Aguado I, Valdovinos M, Larrabide I.

Cir Esp. 2007 Feb;81(2):82-6. Spanish.

20.

Mesothelioma: treatment and survival of a patient population and review of the literature.

Stathopoulos J, Antoniou D, Stathopoulos GP, Rigatos SK, Dimitroulis J, Koutandos J, Michalopoulou P, Athanasiades A, Veslemes M.

Anticancer Res. 2005 Sep-Oct;25(5):3671-6. Review.

Items per page

Supplemental Content

Write to the Help Desk